Connection

SALIM VIRANI to Oligonucleotides, Antisense

This is a "connection" page, showing publications SALIM VIRANI has written about Oligonucleotides, Antisense.
Connection Strength

0.175
  1. Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective. Cardiovasc Drugs Ther. 2021 12; 35(6):1269-1279.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.